Business
Pharmaceutical company Pfizer asks US regulators to allow emergency use of its experimental COVID-19 vaccine – ABC News
Pharmaceutical company Pfizer formally asks US regulators to allow emergency use of its COVID-19 vaccine, starting the clock on a process that could bring limited…
Pharmaceutical company Pfizer has formally asked US regulators to allow emergency use of its COVID-19 vaccine, starting the clock on a process that could bring limited first shots as early as next month.
Key points:
- How much vaccine is available and when is a moving target, but initial supplies will be scarce
- Globally, Pfizer has estimated it could have 50 million doses available by year’s end
- The US Government has a contract to buy millions of Pfizer-BioNTech doses
The action comes days after Pfizer…
Continue Reading
-
Noosa News11 hours agoConsolidated Pastoral Company buys Beetaloo aggregation in historic deal worth more than $300m
-
Business22 hours agoWhat Warren Buffett’s latest portfolio moves say about the market
-
Business16 hours agoCounter drone company surges past $1 billion valuation with new contract win
-
General18 hours agoWotjobaluk Nations Festival marks landmark native title recognition